INVITROLIZE

INVITROLIZE

Private
Belvaux, Canton of Esch-sur-AlzetteHealthcare & Life Scienceshttps://invitrolize.com

Last Round

Seed

May 8, 2025

Total Funding Raised

$53,000

Momentum Score

50 /100

Company Overview

INVITROLIZE is a biotechnology company that provides an advanced solution for respiratory safety testing. A spin-off from the Luxembourg Institute of Science and Technology (LIST), the company developed ALIsens®, a patented 3D in vitro model of the human alveolar barrier. This technology allows for the identification of respiratory sensitizers and irritants from inhalable compounds without resorting to animal testing. The company serves the pharmaceutical, cosmetic, chemical, and consumer goods industries by offering a more accurate, ethical, and regulatory-compliant method for chemical safety assessment. INVITROLIZE secured seed funding in 2025 to expand its operations in Europe and the United States.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

in vitro testingalternative to animal testingrespiratory toxicity3D cell culturein vitro lung modellung-on-a-chippredictive toxicologyContract Research OrganizationCROrespiratory sensitizationhazard identificationin vitro toxicologyNew Approach MethodologiesNAMsair-liquid interfacetoxicity testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

INVITROLIZE Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

INVITROLIZE Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMay 8, 2025
AcceleratorOct 20, 2023

Key People

Founding team and executive leadership

Asier Sesma

Chief Operating Officer

Executive Team

INVITROLIZE Investors

Notable investors and investment history

InvestorRounds
Expon CapitalSeed
Fit 4 StartAccelerator, Seed

INVITROLIZE Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

INVITROLIZE Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about INVITROLIZE's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelvaux, Canton of Esch-sur-Alzette
Employee Range5
Year Founded2022
Last FundingMay 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.